Abstract:Sornsiri Yimlamai, Kanokpan Ruangnapa, Wanaporn Anuntaseree, Kantara Saelim, Pharsai Prasertsan, Kantisa Sirianansopa Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, 90110, Thailand Correspondence: Kanokpan Ruangnapa, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat-Yai, Songkhla, 90110, Thailand, Tel +66-74-451250-1, Fax +66-74-451250-3, Email Purpose: It is still unclear whether considering abnormal spirometry as a marker for disease control can help physicians adjust asthma controllers in children because of the scarcity of pediatric studies. We aimed to investigate the prevalence of abnormal spirometry in a selected pediatric asthmatic population and its effect on longitudinal outcomes. Patients and Methods: This retrospective cohort study was conducted at the Songklanagarind Hospital, Thailand. Children with asthma aged < 18 years were recruited for review if they attended the clinic and underwent acceptable spirometry with bronchodilator responsiveness (BDR) tests after receiving asthma treatment for at least 3 months between January 2011 and June 2022. Differences in baseline characteristics, atopic factors, asthma treatment, and outcomes were analyzed between the normal and abnormal spirometry groups over a 12-month post-spirometry period. Results: The mean age of the 203 enrolled patients was 10.9 ± 2.6 years. Abnormal spirometry, defined as airflow limitation or the presence of BDR, was observed in 58.1% of patients. No significant differences were observed in baseline characteristics, atopic factors, asthma treatment, or outcomes between the normal and abnormal spirometry groups. Further analysis of 107 patients with abnormal spirometry with symptom control revealed that physicians adjusted the asthma controller based on spirometry and symptoms in 84 and 23 patients, respectively. There was no significant difference in the loss of disease control over the 12-month post-spirometry period between the two groups. Conclusion: Abnormal spirometry was found in 58.1% of treated school-aged patients with asthma. Abnormal spirometry results were not associated with poor asthma outcomes during the 12-month follow-up. Both symptom-based and spirometry-based adjustments of asthma controllers resulted in comparable symptom control over a 12-month follow-up period in the selected population. Keywords: pulmonary function test, lung function test, childhood asthma, bronchodilator responsiveness Asthma is the most prevalent non-communicable respiratory disease in childhood, affecting 11–13% of children worldwide. 1 Besides symptom control and minimizing the future risk of exacerbations, preserving normal lung function is an important goal of long-term pediatric asthma care. 2 Impaired lung function in children with asthma is associated with an increased risk of chronic airflow obstruction and chronic obstructive pulmonary disease development in early adulthood. 2–4 Therefore, regular assessment of lung function is encouraged in monitoring children with asthma. 2,5 Spirometry is currently the standard tool for assessing lung function in children with asthma. Abnormal spirometry parameters (such as low forced expiratory volume in 1 s [FEV1], low ratio of FEV1 to forced vital capacity [FEV1/FVC], or low forced expiratory flow between 25% and 75% of vital capacity [FEF25–75%], which represents airway dysfunction), are considered predictors of disease severity and long-term prognosis of respiratory health. 3,4 Children with asthma with a lower FEV1 percentage are more likely to have more severe disease and are at a higher risk of exacerbation. 6,7 However, a significant portion of symptom-controlled patients with asthma still have abnormal lung function. 8–11 Airway reversibility is another characteristic feature of asthma that can be assessed via bronchodilator responsiveness (BDR) testing in children with asthma. 2,5 Besides its diagnostic purpose, the persistence of BDR is a marker of poor asthma control and predictive of a good response to inhaled corticosteroids (ICS). 12,13 Previous studies have reported evidence of airway reversibility in children with asthma with good asthma control or normal lung function. 14,15 These controversial findings affect the role of spirometry and BDR testing in asthma management. However, because of the scarcity of pediatric studies, it is still unclear whether, besides symptom assessment, considering abnormal lung function or the presence of BDR as another marker for disease control can help physicians adjust asthma controllers in children. Hence, we aimed to investigate the prevalence of abnormal spirometry results in -Abstract Truncated-

Late Breaking Abstract - Assessing the diagnostic accuracy of home spirometry system for asthma diagnosis

Clinical significance of FEV0.5 and FEV0.75 in the determination of pulmonary function in children with bronchial asthma

Circadian Rhythm and Variability of Large and Small Airway Spirometric Variables in Healthy Individuals

What is the Best Way to Diagnose Possible Asthma Patients with Negative Bronchodilator Reversibility Tests?

Diagnostic differentiation between asthma and COPD in primary care using lung function testing

Accuracy, Reproducibility, and Responsiveness to Treatment of Home Spirometry in Cystic Fibrosis: Multicenter, Retrospective, Observational Study

Clinic vs Home Spirometry for Monitoring Lung Function in Patients With Asthma

Small-Airway Function Variables in Spirometry, Fractional Exhaled Nitric Oxide, and Circulating Eosinophils Predicted Airway Hyperresponsiveness in Patients with Mild Asthma.

Bronchodilator reversibility in asthma and COPD: findings from three large population studies

A physiologist-led home spirometry assessment (PLHSA) facilitates respiratory diagnosis and treatment pathways

Monitoring respiratory function with telemedicine devices in asthmatic children

30-day Spirometry Holter method design and prospective observational study

Real-world feasibility of short-term, unsupervised home spirometry in CF

Asthma diagnosis: a comparison of established diagnostic guidelines in adults with respiratory symptoms

Spirometric Changes in Bronchodilation Tests as Predictors of Asthma Diagnosis and Treatment Response in Patients with FEV1 ≥ 80% Predicted

A Longitudinal Study of a Selected Pediatric Asthmatic Population with Normal and Abnormal Spirometry at Baseline: An Emphasis on Treatment Outcomes

Overall and peripheral lung function assessment by spirometry and forced oscillation technique in relation to asthma diagnosis and control

Variability in forced expiratory volume in 1 s in children with symptomatically well-controlled asthma

Validation of an App-Based Portable Spirometer in Adolescents with Asthma.

Assessment of functional diversities in patients with Asthma, COPD, Asthma-COPD overlap, and Cystic Fibrosis (CF)

(FEV3-FEV1)/FVC: a Terminal-Airflow Variable for Airway Hyperresponsiveness and Inflammation Prediction in Patients with Symptoms Despite Preserved Spirometry